Clinical Features	Time to Death		AGE		GENDER		KARNOFSKY.PERFORMANCE.SCORE		PATHOLOGY.T		PATHOLOGY.N		PATHOLOGICSPREAD(M)		TUMOR.STAGE	
	nMutated (%)	nWild-Type	logrank test_P	logrank test_Q	t-test_P	t-test_Q	Fisher's exact test_P	Fisher's exact test_Q	t-test_P	t-test_Q	Fisher's exact test_P	Fisher's exact test_Q	Fisher's exact test_P	Fisher's exact test_Q	Fisher's exact test_P	Fisher's exact test_Q	Fisher's exact test_P	Fisher's exact test_Q
MET	7 (7%)	94	0.69475	1	0.88129	1	1	1	NA	NA	1	1	NA	NA	1	1	0.79867	1
IL32	4 (4%)	97	9.4369e-15	4.15e-13	0.36596	1	0.30035	1	NA	NA	0.77595	1	NA	NA	0.21997	1	0.66668	1
CDC27	4 (4%)	97	0.59803	1	0.78002	1	0.59494	1	NA	NA	0.77595	1	NA	NA	0.13186	1	0.34477	1
NF2	7 (7%)	94	0.59803	1	0.29995	1	1	1	NA	NA	0.43746	1	0.058263	1	0.036348	1	0.16224	1
SFRS2IP	5 (5%)	96	0.22626	1	0.12113	1	0.66071	1	NA	NA	0.10185	1	1	1	0.082927	1	0.31589	1
LGI4	4 (4%)	97	0.19047	1	0.90988	1	0.30035	1	NA	NA	0.77595	1	NA	NA	0.71495	1	0.66668	1
BHMT	3 (3%)	98	0.38267	1	0.70319	1	0.54891	1	NA	NA	1	1	NA	NA	0.62692	1	0.56227	1